Turkey
MD Research & Development, founded in 2017 and headquartered in Turkey, is a promising player in the Biotechnology and Medical Devices industries. Operating under the slogan, "Innovation for Precision," the company is dedicated to enhancing the sensitivity and accuracy of cancer treatments, particularly in the field of radiation oncology.
Their commitment to developing innovative products and methods aims to significantly benefit cancer patients, showcasing their strong focus on impactful outcomes in public health. Since its inception, the company has been on a steady trajectory of research and development, establishing itself as a potential disruptor in its niche market.
In its most recent funding round, MD Research & Development secured a $50.00K seed investment on 01 May 2020. This round was backed by an impressive lineup of investors including TRANGELS, İTÜ ARI Teknokent, and notable individuals such as Okan Erol, emre erginler, and Nalan Uysal, which underscores the company's growing credibility and potential in the market.
